From Skrmetti to Medina to Mahmoud, the Supreme Court has been busy issuing devastating rulings on cases that carry profound implications for LGBTQI+ health and rights and reproductive health and rights. Chris Geidner, author of Law Dork, sits down to talk with us about these recent cases out of the Supreme Court, and what these rulings mean for our rights and wellbeing.

In April 2025, some organizations and health centers receiving Title X funding were given sudden notice by the current administration that critical funding would be withheld. This action by the federal government threatens roughly $65.8 million in Title X funds and implicates an estimated 846,000 patients. It has resulted in massive layoffs, stopped contracts, mental strain, and confusion for both employees and patients. We sit down with co-founders and executive directors of some of these impacted organizations, including:

Michelle Trupiano, Executive Director for the Missouri Family Health Council, and

Danielle Lampton, and Jamie Bardwell, Co-Founder and Co-Executive Directors at Converge in Jackson, Mississippi

Immediately after the Dobbs v. Jackson Women’s Health Organization Supreme Court case that overturned Roe v. Wade,shock, sadness, and anger were predominant. But even still, abortion providers, abortion fund workers, and other advocates and leaders in the field provided, facilitated, and fought for access to care. Carole Joffe, professor of obstetrics, gynecology and reproductive sciences at the University of California, San Francisco and professor emerita of sociology at UC Davis, and David Cohen, law professor at Drexel's Klein School of Law in Philadelphia and pro bono counsel to a number of Pennsylvania abortion clinics, sit down to talk with us about their book, After Dobbs: How the Supreme Court Ended Roe but not Abortion.

2/3 of Massachusetts voters support expanding access to abortion later in pregnancy, according to recent polling. Massachusetts still has on the books a 24-week abortion ban, with additional exceptions later added. Jeanette Kincaid, Associate Director of Care Coordination at DuPont Clinic and Kate Dineen, abortion later in pregnancy patient and advocate and Board Member of Reproductive Equity Now, sit down to talk with us about Massachusetts’ abortion access status and the reality of exceptions.

The One Big Beautiful Bill is a reconciliation bill which passed the House and has moved on to the Senate. Included in this bill are provisions that would defund Planned Parenthood, threaten health insurance access, undermine access to abortion and gender-affirming-care nationwide, and raise costs on working families. Ianthe Metzger, Senior Director, Advocacy Communications at Planned Parenthood, sits down to talk with us about this insidious bill and how it, among other things, threatens the care Planned Parenthood provides.

Mifepristone is the first (and extremely safe) of two medications that people will take during a medication abortion—and access to it is under blatant attack in the courts. Dr. Ushma Upadhyay, Public Health Scientist based at University of California San Francisco, and Julia Kaye, Senior Staff Attorney with the ACLU’s Reproductive Freedom Project, sit down to talk with us about recent anti-abortion propaganda and how it could be used to shape the FDA’s regulations of medication abortion.

There are many reasons why someone may require a third-trimester abortion, including both fetal implications and maternal implications (such as health diagnoses and difficult life circumstances). Dr. Shelley Sella, retired OB-GYN, first woman to openly provide third-trimester abortion care in the U.S., and author of Beyond Limits: Stories of Third-Trimester Abortion Care, sits down to share her expertise, discuss the multitude of reasons why someone seeks a third-trimester abortion, and touch on the personal stories shared in the book.

Global reproductive rights and investment in the agencies and organizations that support reproductive rights have often been used as a political football. The bodies of women, girls, and LGBTQI+ persons have been used to push and pull power for decades—and this anti-rights, anti-choice framework has become increasingly exported around the world. Beth Schlachter, Senior Director for U.S. and External Engagement for MSI Reproductive Choices, talks to us about how attacks to human rights frameworks and funding will further endanger global reproductive health and rights.

Title X, under the Public Health Services Act, allows for a family planning and reproductive health-based pool of funding that government agencies and nonprofits can apply for and use to support patients. Providers who receive Title X funding see all patients regardless of insurance status and income level. Clare Coleman, President and CEO of the National Family Planning and Reproductive Health Association (NFPRHA), sits down to talk with us about the recent and extremely harmful changes to Title X announced by the new administration.